Detection of Soluble Amyloid-β Oligomers and Insoluble High-Molecular-Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer's Disease

Detection of Soluble Amyloid-β Oligomers and Insoluble High-Molecular-Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer's Disease

The diagnosis of probable Alzheimer's disease (AD) can be established premortem based on clinical criteria like neuropsychological tests. Post mortem, specific neuropathological changes like amyloid plaques define AD. However, the standard criteria based on medical history and mental status exa...

Full description

Bibliographic Details
Main Author:	Susanne Aileen Funke
Format:	Article
Language:	English
Published:	Hindawi Limited 2011-01-01
Series:	International Journal of Alzheimer's Disease
Online Access:	http://dx.doi.org/10.4061/2011/151645

Similar Items

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease
by: Audrey Hector, et al.
Published: (2021-01-01)

β-amyloid oligomers in aging and Alzheimer's disease
by: Kathleen R. Zahs, et al.
Published: (2013-07-01)

Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
by: Claudia Balducci, et al.
Published: (2019-07-01)

Soluble amyloid-b oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
by: Sergio T. Ferreira, et al.
Published: (2015-05-01)

Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease.
by: Takashi Kasai, et al.
Published: (2017-01-01)

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
by: Barbara Mroczko, et al.
Published: (2018-06-01)

Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease
by: Marcos J. Guerrero-Muñoz, et al.
Published: (2014-11-01)

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
by: Oskar Hansson, et al.
Published: (2019-04-01)

Soluble amyloid-β aggregates in Alzheimer’s disease
by: Englund, Hillevi
Published: (2009)

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
by: Adla Boumenir, et al.
Published: (2019-03-01)

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.
by: Mikko Hölttä, et al.
Published: (2013-01-01)

Postsynaptic Receptors for Amyloid-β Oligomers as mediators of neuronal damage in Alzheimer's Disease
by: Margarita C. Dinamarca, et al.
Published: (2012-12-01)

Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin
by: Langen Ralf, et al.
Published: (2008-10-01)

Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains.
by: Sebastian Jimenez, et al.
Published: (2014-01-01)

Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
by: Joohyun Park, et al.
Published: (2013-07-01)

The Toxicity and Polymorphism of β-Amyloid Oligomers
by: Ya-ru Huang, et al.
Published: (2020-06-01)

Breaking the Code of Amyloid-β Oligomers
by: Sylvain E. Lesné
Published: (2013-01-01)

A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid.
by: Adrianna Z Herskovits, et al.
Published: (2013-01-01)

Stabilization of a Membrane-Associated Amyloid-β Oligomer for Its Validation in Alzheimer's Disease
by: Montserrat Serra-Batiste, et al.
Published: (2018-04-01)

Amyloid-β Oligomers Unveil a Novel Primate Model of Sporadic Alzheimer’s Disease
by: Joseph eJebelli, et al.
Published: (2015-03-01)

Alzheimer's Amyloid-β Oligomers Reverse Cellular Prion Protein Induced Tau Reduction
by: Rong-Jie Chen, et al.
Published: (2014)

Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile.
by: Peng Liu, et al.
Published: (2015-01-01)

Capture of Amyloid-β Oligomers by Magnetic Stirring as a New Therapeutic Strategy for Alzheimer's Disease
by: Lun, Jing-Chian, et al.
Published: (2018)

Reduced CSF Water Influx in Alzheimer's Disease Supporting the β-Amyloid Clearance Hypothesis.
by: Yuji Suzuki, et al.
Published: (2015-01-01)

BIOORGANIC STUDIES ON RECOGNITION OF SOLUBLE AMYLOID OLIGOMERS USING SMALL MOLECULES
by: Smith, Nicholas W.
Published: (2011)

Probing the Occurrence of Soluble Oligomers through Amyloid Aggregation Scaling Laws
by: Alexandra Silva, et al.
Published: (2018-10-01)

Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
by: Martin Tolar, et al.
Published: (2021-06-01)

Mutations in the β-amyloid precursor protein in familial Alzheimer’s disease increase Aβ oligomer production in cellular models
by: Yoichi Ohshima, et al.
Published: (2018-01-01)

Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer’s disease related oligomers
by: Tobias Lieblein, et al.
Published: (2020-10-01)

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease
by: Xue Meng, et al.
Published: (2019-10-01)

Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease
by: Yuan Zhang, et al.
Published: (2019-07-01)

Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures
by: Clive Bate, et al.
Published: (2018-03-01)

Multidisniplinary study of Alzheimer's disease-related peptides : from amyloid precursor protein (APP) to amyloid β-oligomers and γ-secretase modulators
by: Itkin, Anna
Published: (2012)

Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
by: Natalia Salvadores, et al.
Published: (2014-04-01)

Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer’s Disease Brains
by: Luis O. Soto-Rojas, et al.
Published: (2021-04-01)

The (Soluble and Insoluble) Paradoxes Of Toleration
by: Ricardo Corrêa de Araujo
Published: (2019-03-01)

Mitochondrial ubiquitin ligase alleviates Alzheimer’s disease pathology via blocking the toxic amyloid-β oligomer generation
by: Keisuke Takeda, et al.
Published: (2021-02-01)

Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol
by: Ming Jin, et al.
Published: (2015-10-01)

Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
by: Daniel Alcolea, et al.
Published: (2019-09-01)

Amyloid β oligomers inhibit growth of human cancer cells.
by: Bozena Pavliukeviciene, et al.
Published: (2019-01-01)